Published date: 3 October 2019

This notice was replaced on 7 January 2020

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 7 January 2020)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Pharmaceutical products - 33600000

Location of contract

Any region

Value of contract

£1,900,000

Procurement reference

tender_219286/803013

Published date

3 October 2019

Closing date

5 November 2019

Contract start date

1 January 2020

Contract end date

31 December 2020

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

National Framework Agreement for the Supply of Lanadelumab

Offer reference number: CM/PHS/18/5570

Period of framework agreement: 1st January 2020 - 31st December 2020 with options to extend up to a further 36 months. Total maximum framework agreement including extension options will be no more than 48 months

More information

Attachments

About the buyer

Address

Commercial Medicines Unit, Rutland House
Runcorn
WA7 2AA
England

Email

wendy.roach@nhs.net